title: [Factors influencing the result of kidney transplantation with special reference to the HLA system in conventional immunosuppression].
abstract: Among 331 recipients of cadaveric renal allografts, transplanted from 1976 to 1986 at the Rostock Transplant Center the graft survival rates have been analyzed. All patients have been treated by conventional immunosuppressive therapy using azathioprine and prednisolone. A relation between graft survival and immunological factors was found: the better the HLA match, the better the transplant results. The necessity of a restrictive transfusion regime was stressed. The higher the number of pretransplant transfusions, the higher is the panel reactivity with following lower graft survival. Cold ischemic time was without influence on graft survival. The introduction of cyclosporin may improve the graft survival rate as known of 10-20%.
authors.affiliation: Bezirks-Institut für Blutspende- und Transfusionswesen Rostock.
authors.forename: S
authors.initials: S
authors.lastname: Wegener
authors.forename: M
authors.initials: M
authors.lastname: Auner
authors.forename: R
authors.initials: R
authors.lastname: Templin
authors.forename: E
authors.initials: E
authors.lastname: Schmitt
authors.forename: T
authors.initials: T
authors.lastname: Erdmann
authors.forename: G
authors.initials: G
authors.lastname: Fünfhausen
mesh_terms: D001379:Azathioprine / Q000008:administration & dosage*; D001803:Blood Transfusion; D003928:Diabetic Nephropathies / Q000601:surgery; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D006680:HLA Antigens / Q000032:analysis*; D006684:HLA-DR Antigens / Q000032:analysis; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D011239:Prednisolone / Q000008:administration & dosage*
chemical_list: D006680:HLA Antigens; D006684:HLA-DR Antigens; D011239:Prednisolone; D001379:Azathioprine
vernacular_title: Einflussfaktoren auf das Nierentransplantationsergebnis unter besonderer Berücksichtigung des HLA-Systems bei konventioneller Immunsuppression.